The fact that IL-1R−/− mice were protected more from developing T1DM upon streptozotocin (STZ) treatment also suggested that NLRP3-IL-1β signaling contributed to pancreatic islet inflammation, β cell damage, and ultimately T1DM development [26]. This evidence concerns the gene NLRP3 and type 1 diabetes mellitus.